首页 | 本学科首页   官方微博 | 高级检索  
     

肺癌患者外周血调节性T细胞和IL-10的检测及其意义
引用本文:翟晋芳,杜凤兰,绳晋雅,郭志娟. 肺癌患者外周血调节性T细胞和IL-10的检测及其意义[J]. 中国肿瘤临床, 2012, 39(6): 325-327. DOI: 10.3969/j.issn.1000-8179.2012.06.007
作者姓名:翟晋芳  杜凤兰  绳晋雅  郭志娟
作者单位:山西省肿瘤医院呼吸一科(太原市030013)
摘    要:  目的  探讨肺癌患者外周血调节性T细胞和IL-10检测的诊断意义及与临床特征相关性。  方法  采用流式细胞仪检测60例肺癌患者外周血中CD4+CD25+T细胞的表达水平, 同时采用ELISA法检测IL-10的表达水平。并随机选30例健康体检者作为对照组。  结果  肺癌患者外周血中CD4+CD25+T细胞和IL-10的表达水平明显高于健康对照组(P < 0. 05); CD4+CD25+T细胞与IL-10的检测结果呈正相关; 肺癌患者外周血中CD4+CD25+T细胞和IL-10的表达水平与临床分期有关(P < 0. 05), 与病理类型无关(P>0. 05)。  结论  检测肺癌患者外周血中CD4+CD25+T细胞和IL-10的表达水平, 有助于肺癌患者病情的评估和治疗。 

关 键 词:肺癌   CD4+CD25+T细胞   IL-10
收稿时间:2011-12-26

Detection of CD4+CD25+ T-Cells and IL-10 in Peripheral Blood of Lung Cancer Patients ant Its Significance
Jinfang ZHAI , Fenglan DU , Jinya SHENG , Zhijuan GUO. Detection of CD4+CD25+ T-Cells and IL-10 in Peripheral Blood of Lung Cancer Patients ant Its Significance[J]. Chinese Journal of Clinical Oncology, 2012, 39(6): 325-327. DOI: 10.3969/j.issn.1000-8179.2012.06.007
Authors:Jinfang ZHAI    Fenglan DU    Jinya SHENG    Zhijuan GUO
Affiliation:The First Department of Respiratory Medicine, Shanxi Provincial Tumor Hospital, Taiyuan 030013, China
Abstract:  Objective  This study discusses the relationship of the CD4+CD25+T-cells and IL-10 in the peripheral blood of lung cancer patients with clinicopathologic features.  Methods  The amounts of CD4+CD25+T-cells in the peripheral blood samples from 60 patients were measured using flow cytometry, whereas the amounts of IL-10 were measured using enzyme-linked immunosorbent assay. Blood samples from 30 healthy volunteers were also collected and examined.  Results  The amounts of CD4+CD25+T-cells and IL-10 in the peripheral blood samples from lung cancer patients were significantly higher than those from the healthy volunteers (P < 0.05). Moreover, the amounts of CD4+CD25+T-cells and IL-10 were positively correlated. Finally, the amounts of CD4+CD25+T-cells and IL-10 were correlated with the clinical stage of the disease (P < 0.05) but were not associated with the pathological classification (P > 0.05).  Conclusion  Determining the amounts of CD4+CD25+ T-cells and IL-10 may help in the assessment and therapy of lung cancer patients. 
Keywords:
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号